PMC:7029759 / 1048-1297 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"38","span":{"begin":230,"end":239},"obj":"Species"}],"attributes":[{"id":"A38","pred":"tao:has_database_id","subj":"38","obj":"Tax:2697049"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"promise and pitfalls of these approaches. Finally, I advocate for the fastest strategy to develop a treatment now, which could be resistant to any mutations the virus may have in the future. The proposal is a biologic that blocks 2019-nCoV entry usi"}

{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T19","span":{"begin":161,"end":166},"obj":"NCBITaxon:10239"},{"id":"T18","span":{"begin":230,"end":239},"obj":"SP_7"}],"text":"promise and pitfalls of these approaches. Finally, I advocate for the fastest strategy to develop a treatment now, which could be resistant to any mutations the virus may have in the future. The proposal is a biologic that blocks 2019-nCoV entry usi"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T7","span":{"begin":98,"end":99},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T8","span":{"begin":161,"end":166},"obj":"http://purl.obolibrary.org/obo/NCBITaxon_10239"},{"id":"T9","span":{"begin":207,"end":208},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"}],"text":"promise and pitfalls of these approaches. Finally, I advocate for the fastest strategy to develop a treatment now, which could be resistant to any mutations the virus may have in the future. The proposal is a biologic that blocks 2019-nCoV entry usi"}

{"project":"LitCovid-sentences","denotations":[{"id":"T11","span":{"begin":42,"end":190},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"promise and pitfalls of these approaches. Finally, I advocate for the fastest strategy to develop a treatment now, which could be resistant to any mutations the virus may have in the future. The proposal is a biologic that blocks 2019-nCoV entry usi"}